Laporan Keuangan Ringkasan laba rugi, neraca, dan arus kas — INAF Indofarma Tbk.
| Dalam Jutaan IDR | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Total Pendapatan | 151,551 | 133,735 | 67,029 | 36,762 | 210,380 | 137,870 | 109,718 | 43,637 |
| Total Beban Pokok Penjualan | (170,767) | (145,310) | (76,989) | (42,365) | (247,887) | (149,672) | (108,385) | (43,347) |
| Laba Kotor | (19,217) | (11,575) | (9,961) | (5,603) | (37,508) | (11,802) | 1,333 | 291 |
| Laba Kotor Setelah Ventura Bersama | (18,750) | (11,575) | (9,961) | (5,603) | (36,996) | (11,802) | 1,333 | 291 |
| Total Beban Usaha | (102,333) | (100,944) | (30,812) | (16,590) | (230,845) | (120,295) | (75,374) | (42,594) |
| Laba Usaha | (121,083) | (112,519) | (40,773) | (22,193) | (267,840) | (132,096) | (74,041) | (42,304) |
| Penghasilan/Beban Lain-Lain | 49,627 | (5,981) | (3,520) | (3,245) | (15,918) | (35,062) | (28,062) | (11,917) |
| Laba Sebelum Pajak | (71,455) | (118,500) | (44,292) | (25,438) | (283,758) | (167,158) | (102,103) | (54,220) |
| Beban Pajak Penghasilan | (6,534) | (8,591) | 740 | 329 | (50,734) | 674 | 164 | 277 |
| Laba Bersih Dari Operasi Yang Dilanjutkan | (77,989) | (127,091) | (43,552) | (25,109) | (334,492) | (166,484) | (101,939) | (53,944) |
| Hak Minoritas | - | - | - | - | - | - | - | - |
| Penyesuaian Proforma | - | - | - | - | - | - | - | - |
| Laba Bersih Tahun Berjalan | (77,989) | (127,091) | (43,552) | (25,109) | (334,492) | (166,484) | (101,939) | (53,944) |
| Pendapatan Komprehensif Lain | - | - | - | - | (4,164) | - | - | - |
| Jumlah Laba Komprehensif | (77,989) | (127,091) | (43,552) | (25,109) | (338,656) | (166,484) | (101,939) | (53,944) |
| Laba Bersih Yang Dapat Diatribusikan | (77,989) | (127,091) | (43,552) | (25,109) | (334,492) | (166,484) | (101,939) | (53,944) |
| Laba Komprehensif Yang Dapat Diatribusikan | (77,989) | (127,091) | (43,552) | (25,109) | (338,656) | (166,484) | (101,939) | (53,944) |
Key Ratios — INAF
| Rasio | Q4 2025 | Q3 2025 ×1⅓ | Q2 2025 ×2 | Q1 2025 ×4 | Q4 2024 | Q3 2024 ×1⅓ | Q2 2024 ×2 | Q1 2024 ×4 |
|---|---|---|---|---|---|---|---|---|
| Profitabilitas | ||||||||
| Gross Margin (%) | 12.68% | 8.65% | 14.86% | 15.24% | 17.83% | 8.56% | 1.22% | 0.67% |
| Operating Margin (%) | 79.90% | 84.14% | 60.83% | 60.37% | 127.31% | 95.81% | 67.48% | 96.94% |
| Net Margin (%) | 51.46% | 95.03% | 64.98% | 68.30% | 158.99% | 120.75% | 92.91% | 123.62% |
| ROE (%) | 11.03% | 19.02% | 10.79% | 12.73% | 29.24% | 22.87% | 22.50% | 25.15% |
| ROA (%) | 14.55% | 29.14% | 15.56% | 17.50% | 54.11% | 29.27% | 24.82% | 27.24% |
| Per Lembar Saham | ||||||||
| EPS (Rp) | 25,16 | 54,68 | 28,10 | 32,41 | 107,93 | 71,62 | 65,78 | 69,62 |
| BVPS (Rp) | 228,10 | 287,47 | 260,51 | 254,56 | 369,13 | 313,18 | 292,35 | 276,86 |
| Valuasi | ||||||||
| PER (x) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PBV (x) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Struktur Modal | ||||||||
| DER (x) | 1.76x | 1.65x | 1.69x | 1.73x | 1.54x | 1.78x | 1.91x | 1.92x |